Literature DB >> 9175252

Evidence that fatal human infections with La Crosse virus may be associated with a narrow range of genotypes.

C Huang1, W H Thompson, N Karabatsos, L Grady, W P Campbell.   

Abstract

La Crosse (LAC) virus belongs to the California (CAL) serogroup of the genus Bunyavirus, family Bunyaviridae. It is considered one of the most important mosquito-borne pathogens in North America, especially in the upper Mid-West, where it is associated with encephalitis during the time of year when mosquitoes are active. Infections occur most frequently in children and young adults and, while most cases are resolved after a period of intense illness, a small fraction (< 1%) are fatal. At present there have only been three isolates of LAC virus from humans all made from brain tissue postmortem. The cases yielding viruses are separated chronologically by 33 years and geographically from Minnesota/Wisconsin (1960, 1978) to Missouri (1993). The M RNA sequence of the first two isolates was previously reported. The present study extends the observations to the isolate from the 1993 case and includes several mosquito isolates as well. A comparison of the M RNAs of these viruses shows that for the human isolates both nucleotide sequence and the deduced amino-acid sequence of the encoded proteins are highly conserved, showing a maximum variation of only 0.91% and 0.69%, respectively. This high degree of conservation over time and space leads to the hypothesis that human infections with this particular genotype of LAC virus are those most likely to have a fatal outcome. It is also shown that a virus with this genotype could be found circulating in mosquitoes in an area more or less intermediate between the locations of the first and second fatal cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175252     DOI: 10.1016/s0168-1702(97)01437-8

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  13 in total

1.  Nucleic acid amplification assays for detection of La Crosse virus RNA.

Authors:  Amy J Lambert; Roger S Nasci; Bruce C Cropp; Denise A Martin; Becky C Rose; Brandy J Russell; Robert S Lanciotti
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

2.  Characterization of La Crosse virus RNA in autopsied central nervous system tissues.

Authors:  L J Chandler; M K Borucki; D K Dobie; L P Wasieloski; W H Thompson; C B Gundersen; K Case; B J Beaty
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

3.  Rapid detection of human pathogenic orthobunyaviruses.

Authors:  Manfred Weidmann; Veronique Rudaz; Marcio R T Nunes; Pedro F C Vasconcelos; Frank T Hufert
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

4.  Identification of super-infected Aedes triseriatus mosquitoes collected as eggs from the field and partial characterization of the infecting La Crosse viruses.

Authors:  Sara M Reese; Eric C Mossel; Meaghan K Beaty; Eric T Beck; Dave Geske; Carol D Blair; Barry J Beaty; William C Black
Journal:  Virol J       Date:  2010-04-22       Impact factor: 4.099

5.  Passenger Mutations Confound Phenotypes of SARM1-Deficient Mice.

Authors:  Melissa B Uccellini; Susana V Bardina; Maria Teresa Sánchez-Aparicio; Kris M White; Ying-Ju Hou; Jean K Lim; Adolfo García-Sastre
Journal:  Cell Rep       Date:  2020-04-07       Impact factor: 9.423

6.  The spatial epidemiology and clinical features of reported cases of La Crosse virus infection in West Virginia from 2003 to 2007.

Authors:  Andrew D Haddow; Danae Bixler; Agricola Odoi
Journal:  BMC Infect Dis       Date:  2011-01-26       Impact factor: 3.090

7.  The incidence risk, clustering, and clinical presentation of La Crosse virus infections in the eastern United States, 2003-2007.

Authors:  Andrew D Haddow; Agricola Odoi
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

8.  La Crosse Virus Disease in the United States, 2003-2019.

Authors:  Grace M Vahey; Nicole P Lindsey; J Erin Staples; Susan L Hills
Journal:  Am J Trop Med Hyg       Date:  2021-07-19       Impact factor: 3.707

9.  Potential for La Crosse virus segment reassortment in nature.

Authors:  Sara M Reese; Bradley J Blitvich; Carol D Blair; Dave Geske; Barry J Beaty; William C Black
Journal:  Virol J       Date:  2008-12-30       Impact factor: 4.099

10.  La Crosse virus infectivity, pathogenesis, and immunogenicity in mice and monkeys.

Authors:  Richard S Bennett; Christina M Cress; Jerrold M Ward; Cai-Yen Firestone; Brian R Murphy; Stephen S Whitehead
Journal:  Virol J       Date:  2008-02-11       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.